BWCGF yields 2380.95% · PFE yields 6.13%● Live data
📍 BWCGF pulled ahead of the other in Year 1
Combined, BWCGF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BWCGF + PFE for your $10,000?
Blackwolf Copper and Gold Ltd., together with its subsidiaries, engages in the acquisition, exploration, and development of mineral properties. It explores for copper, gold, zinc, and silver deposits. The company holds a 100% interest in the Niblack Project, which consists of an area of approximately 6,200 acres located on Prince of Wales Island in Southeast Alaska, the United States; and Hyder Properties that consists of Texas Creek, Cantoo, and Casey properties covering an area of 3,863 hectares situated in Southeast Alaska, the United States. It also holds a 100% interest in the Mineral Hill gold, silver, and polymetallic property that comprises of 60 claims covering an area of 502 hectares located in Golden Triangle, Alaska. The company was formerly known as Heatherdale Resources Ltd. and changed its name to Blackwolf Copper and Gold Ltd. in April 2021. Blackwolf Copper and Gold Ltd. was incorporated in 2007 and is based in Vancouver, Canada.
Full BWCGF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.